Codes / ICD10CM / I70.562

I70.562 Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, left leg

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Common Name: Atherosclerosis of Bypass Grafts with Gangrene (Left Leg)
  • Medical Term: Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, left leg
  • ICD-10 Code: I70.562

Summary

Atherosclerosis of nonautologous biological bypass graft(s) of the extremities with gangrene, left leg, describes plaque buildup in biological grafts (e.g., donor veins or arteries) used to bypass blocked arteries in the left leg, resulting in severe narrowing or blockage of blood flow and tissue death (gangrene). This condition impairs graft patency and limb perfusion, leading to critical ischemia and potential limb loss if not addressed promptly.

Causes

Atherosclerosis in bypass grafts develops due to the accumulation of fatty deposits, cholesterol, and other substances within the graft walls. Over time, these deposits harden and narrow the vessel, restricting blood flow. The process is often linked to systemic atherosclerosis and may be accelerated by factors like inflammation, graft injury, or poor graft integration.

Risk Factors

  • Age (more common in older adults)
  • History of cardiovascular disease
  • High cholesterol or triglyceride levels
  • Hypertension (high blood pressure)
  • Smoking or tobacco use
  • Diabetes or insulin resistance
  • Obesity or sedentary lifestyle
  • Poor diet (high in saturated fats, trans fats, or sodium)
  • Prior bypass surgery

Symptoms

  • Severe leg pain, especially at rest
  • Coldness, numbness, or discoloration of the left leg
  • Non-healing ulcers or sores
  • Tissue death (gangrene) in the left leg
  • Reduced or absent pulses in the left leg
  • Weakness or loss of function in the left leg

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging studies, and laboratory tests. Physical examination may reveal signs of poor circulation, such as coldness or discoloration. Imaging (e.g., Doppler ultrasound, angiography) assesses graft patency and blood flow. Laboratory tests check for infection or metabolic issues. Tissue samples may be taken to confirm gangrene.

Treatment Options

Treatment focuses on restoring blood flow and managing gangrene. Options include revascularization (e.g., graft revision, angioplasty), antibiotics for infection, and wound care. In severe cases, amputation may be necessary. Lifestyle modifications (e.g., smoking cessation, diet changes) and medications (e.g., statins, antiplatelets) are also used to manage underlying conditions.

Prognosis and Follow-Up

Prognosis depends on the extent of gangrene and response to treatment. Early intervention improves outcomes, but severe cases may lead to limb loss. Follow-up includes regular monitoring of graft function, wound healing, and management of risk factors. Long-term care may involve ongoing medication and lifestyle adjustments.

Complications

  • Limb loss (amputation)
  • Infection (e.g., gangrene-related sepsis)
  • Recurrent atherosclerosis in the graft
  • Poor wound healing
  • Chronic pain or disability

Lifestyle & Prevention

  • Quit smoking or avoid tobacco use
  • Maintain a heart-healthy diet (low in saturated fats, high in fiber)
  • Exercise regularly (as tolerated) to improve circulation
  • Manage blood pressure, cholesterol, and blood sugar levels
  • Follow post-surgical care instructions for graft maintenance
  • Attend regular check-ups to monitor graft function

When to Seek Professional Help

Seek immediate medical attention if you experience:

  • Sudden severe leg pain
  • Coldness, numbness, or discoloration of the left leg
  • Non-healing sores or ulcers
  • Signs of infection (e.g., fever, redness, swelling)
  • Changes in leg function or sensation

Tips for Medical Coders

Document the location (left leg) and presence of gangrene to support code I70.562. Include details about the bypass graft type (nonautologous biological) and any contributing factors (e.g., infection, poor perfusion). Ensure clinical documentation aligns with the specific manifestations of the condition for accurate coding.

Book a walkthrough

I70.562 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.